Ireland · Growth startup
Funding summaryUpdated 26 Oct 2026
$27Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Seroba Life Sciences
From Perfuze's own website: 2 founders, 22 on the team.
And 4 more on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Earlybird Venture CapitalLSV Health InvestorsL
EQT Life SciencesL
Seroba.L
EQTEarlybird/ MedFocusMissing a round, or an investor who was in one? Tell us.
This firm lists Perfuze as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Perfuze's investors include Earlybird Venture Capital, SV Health Investors, EQT Life Sciences, Seroba. and EQT, and 1 more on record. Earlybird Venture Capital led its latest round.
Perfuze has raised $27M across 2 rounds since 2019.
Perfuze's most recent round was a Growth of $24M in Mar 2025, led by Earlybird Venture Capital.
Its most recent round, $24M in Mar 2025, is also its largest on record.
Perfuze's first round on record, in Jan 2019, was backed by Earlybird/ MedFocus.
Perfuze's latest named round is a Growth, in Mar 2025.
Perfuze is based in Ireland.
Earlybird Venture Capital led the Growth in 2025.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
Ireland · 
